BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 18410548)

  • 41. Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas.
    Gaspar LM; Gonçalves CI; Saraiva C; Cortez L; Amaral C; Nobre E; Lemos MC
    J Endocrinol Invest; 2023 Nov; 46(11):2299-2307. PubMed ID: 37149543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AIP Mutations are not identified in patients with sporadic pituitary adenomas.
    DiGiovanni R; Serra S; Ezzat S; Asa SL
    Endocr Pathol; 2007; 18(2):76-8. PubMed ID: 17916996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.
    Jaffrain-Rea ML; Rotondi S; Turchi A; Occhi G; Barlier A; Peverelli E; Rostomyan L; Defilles C; Angelini M; Oliva MA; Ceccato F; Maiorani O; Daly AF; Esposito V; Buttarelli F; Figarella-Branger D; Giangaspero F; Spada A; Scaroni C; Alesse E; Beckers A
    Endocr Relat Cancer; 2013 Oct; 20(5):753-66. PubMed ID: 23940012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
    Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
    Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
    Trivellin G; Butz H; Delhove J; Igreja S; Chahal HS; Zivkovic V; McKay T; Patócs A; Grossman AB; Korbonits M
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E708-19. PubMed ID: 22811466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic, molecular and clinical features of familial isolated pituitary adenomas.
    Daly AF; Tichomirowa MA; Beckers A
    Horm Res; 2009 Apr; 71 Suppl 2():116-22. PubMed ID: 19407507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.
    Lloyd C; Grossman A
    Endocrine; 2014 Aug; 46(3):387-96. PubMed ID: 24366639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study.
    Schöfl C; Honegger J; Droste M; Grussendorf M; Finke R; Plöckinger U; Berg C; Willenberg HS; Lammert A; Klingmüller D; Jaursch-Hancke C; Tönjes A; Schneidewind S; Flitsch J; Bullmann C; Dimopoulou C; Stalla G; Mayr B; Hoeppner W; Schopohl J
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2789-93. PubMed ID: 25093619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature.
    Gummadavelli A; Dinauer C; McGuone D; Vining EM; Erson-Omay EZ; Omay SB
    J Clin Neurosci; 2020 Aug; 78():420-422. PubMed ID: 32336638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel C-terminal nonsense mutation, Q315X, of the aryl hydrocarbon receptor-interacting protein gene in a Japanese familial isolated pituitary adenoma family.
    Iwata T; Yamada S; Ito J; Inoshita N; Mizusawa N; Ono S; Yoshimoto K
    Endocr Pathol; 2014 Sep; 25(3):273-81. PubMed ID: 24789813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
    Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
    Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The epidemiology and genetics of pituitary adenomas.
    Daly AF; Tichomirowa MA; Beckers A
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):543-54. PubMed ID: 19945022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the MEN1 gene in sporadic pituitary adenomas.
    Schmidt MC; Henke RT; Stangl AP; Meyer-Puttlitz B; Stoffel-Wagner B; Schramm J; von Deimling A
    J Pathol; 1999 Jun; 188(2):168-73. PubMed ID: 10398160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
    Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
    Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
    Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Aryl hydrocarbon receptor interacting protein gene and familial isolated pituitary adenomas].
    Cai F; Zhang YD; Dai CX; Liu XH; Yang YK; Yao Y; Wang RZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):640-4. PubMed ID: 23286415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1.
    Weil RJ; Vortmeyer AO; Huang S; Boni R; Lubensky IA; Pack S; Marx SJ; Zhuang Z; Oldfield EH
    Clin Cancer Res; 1998 Jul; 4(7):1673-8. PubMed ID: 9676841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.
    Tichomirowa MA; Barlier A; Daly AF; Jaffrain-Rea ML; Ronchi C; Yaneva M; Urban JD; Petrossians P; Elenkova A; Tabarin A; Desailloud R; Maiter D; Schürmeyer T; Cozzi R; Theodoropoulou M; Sievers C; Bernabeu I; Naves LA; Chabre O; Montañana CF; Hana V; Halaby G; Delemer B; Aizpún JI; Sonnet E; Longás AF; Hagelstein MT; Caron P; Stalla GK; Bours V; Zacharieva S; Spada A; Brue T; Beckers A
    Eur J Endocrinol; 2011 Oct; 165(4):509-15. PubMed ID: 21753072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial pituitary adenomas.
    Tichomirowa MA; Daly AF; Beckers A
    J Intern Med; 2009 Jul; 266(1):5-18. PubMed ID: 19522822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.